Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dan Hammer Health is a private health and wellness company focused on consumer education and commercial sales of nitric-oxide-oriented nutritional supplements for cardiovascular wellness and performance support. The company markets ProArgi-9+ and other products from Synergy Worldwide, while also offering proprietary "Nitric Oxide Therapy" protocols, newsletter content, and a preferred-customer/referral program. Its messaging centers on using nitric oxide support and endothelial health optimization to address concerns such as blood pressure, cholesterol, diabetes-related complications, erectile dysfunction, and exercise performance. Based on the available public information, Dan Hammer Health appears to operate as a wellness/nutraceutical business rather than a drug-development biotech or pharmaceutical company, with no disclosed regulated therapeutic pipeline or clinical-stage assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dan Hammer Health.